These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 19435402

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effects of transdermal buprenorphine on patients-reported outcomes in cancer patients: results from the Cancer Pain Outcome Research (CPOR) Study Group.
    Apolone G, Corli O, Negri E, Mangano S, Montanari M, Greco MT, Cancer Pain Outcome Research Study Group (CPOR SG) Investigators, Apolone G, Bertetto O, Caraceni A, Corli O, De Conno F, Labianca R, Maltoni M, Nicora Maria F, Torri V, Zucco F.
    Clin J Pain; 2009 Oct; 25(8):671-82. PubMed ID: 19920716
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
    Clark AJ, Ahmedzai SH, Allan LG, Camacho F, Horbay GL, Richarz U, Simpson K.
    Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. High dose transdermal buprenorphine for moderate to severe pain in spanish pain centres--a retrospective multicenter safety and efficacy study.
    Barutell C, Camba A, González-Escalada JR, Rodríguez M, Opioid Group of the Spanish Society for the Study of Pain.
    Pain Pract; 2008 Sep; 8(5):355-61. PubMed ID: 18662364
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of transdermal buprenorphine in the management of children with cancer-related pain.
    Ruggiero A, Coccia P, Arena R, Maurizi P, Battista A, Ridola V, Attinà G, Riccardi R.
    Pediatr Blood Cancer; 2013 Mar; 60(3):433-7. PubMed ID: 23034996
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.
    Mitra F, Chowdhury S, Shelley M, Williams G.
    Pain Med; 2013 Jan; 14(1):75-83. PubMed ID: 23320402
    [Abstract] [Full Text] [Related]

  • 33. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
    van Seventer R, Smit JM, Schipper RM, Wicks MA, Zuurmond WW.
    Curr Med Res Opin; 2003 Jan; 19(6):457-69. PubMed ID: 14594516
    [Abstract] [Full Text] [Related]

  • 34. Buprenorphine and the transdermal system: the ideal match in pain management.
    Budd K.
    Int J Clin Pract Suppl; 2003 Feb; (133):9-14; discussion 23-4. PubMed ID: 12665118
    [Abstract] [Full Text] [Related]

  • 35. [Application of a seven-day buprenorphine transdermal patch in multimorbid patients on long-term ibuprofen or diclofenac].
    Böhme K, Heckes B, Thomitzek K.
    MMW Fortschr Med; 2011 Jan 13; 152 Suppl 4():125-32. PubMed ID: 21598463
    [Abstract] [Full Text] [Related]

  • 36. Short- and intermediate-term efficacy of buprenorphine TDS in chronic painful neuropathies.
    Penza P, Campanella A, Martini A, Melli G, Lombardi R, Camozzi F, Devigili G, Lauria G.
    J Peripher Nerv Syst; 2008 Dec 13; 13(4):283-8. PubMed ID: 19192068
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Comparable analgesic efficacy of transdermal buprenorphine in patients over and under 65 years of age.
    Likar R, Vadlau EM, Breschan C, Kager I, Korak-Leiter M, Ziervogel G.
    Clin J Pain; 2008 Dec 13; 24(6):536-43. PubMed ID: 18574363
    [Abstract] [Full Text] [Related]

  • 39. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial.
    Mystakidou K, Befon S, Kouskouni E, Gerolymatos K, Georgaki S, Tsilika E, Vlahos L.
    Anticancer Res; 2001 Dec 13; 21(3C):2225-30. PubMed ID: 11501851
    [Abstract] [Full Text] [Related]

  • 40. Challenging the equipotency calculation for transdermal buprenorphine: four case studies.
    Likar R, Krainer B, Sittl R.
    Int J Clin Pract; 2008 Jan 13; 62(1):152-6. PubMed ID: 18173815
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.